Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 2
2008 1
2011 2
2012 2
2013 1
2014 1
2015 1
2016 1
2017 2
2018 6
2019 7
2020 10
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Baricitinib restrains the immune dysregulation in patients with severe COVID-19.
Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Canè S, Batani V, Trovato R, Fiore A, Petrova V, Hofer F, Barouni RM, Musiu C, Caligola S, Pinton L, Torroni L, Polati E, Donadello K, Friso S, Pizzolo F, Iezzi M, Facciotti F, Pelicci PG, Righetti D, Bazzoni P, Rampudda M, Comel A, Mosaner W, Lunardi C, Olivieri O. Bronte V, et al. Among authors: facciotti f. J Clin Invest. 2020 Dec 1;130(12):6409-6416. doi: 10.1172/JCI141772. J Clin Invest. 2020. PMID: 32809969 Free PMC article. Clinical Trial.
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers.
Bruni M, Cecatiello V, Diaz-Basabe A, Lattanzi G, Mileti E, Monzani S, Pirovano L, Rizzelli F, Visintin C, Bonizzi G, Giani M, Lavitrano M, Faravelli S, Forneris F, Caprioli F, Pelicci PG, Natoli G, Pasqualato S, Mapelli M, Facciotti F. Bruni M, et al. Among authors: facciotti f. J Clin Med. 2020 Oct 1;9(10):3188. doi: 10.3390/jcm9103188. J Clin Med. 2020. PMID: 33019628 Free PMC article.
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
Berte' R, Mazza S, Stefanucci MR, Noviello D, Costa S, Ciafardini C, Mileti E, Mapelli M, Pasqualato S, Pinto S, Favale A, Vecchi M, Neurath MF, Atreya R, Fantini MC, Facciotti F, Caprioli F. Berte' R, et al. Among authors: facciotti f. J Crohns Colitis. 2021 May 4;15(5):864-868. doi: 10.1093/ecco-jcc/jjaa237. J Crohns Colitis. 2021. PMID: 33211810 Free PMC article.
44 results